Skip to main content
Collection

Digital Mental Health Technology

Wellcome have funded the MHRA and NICE to focus on clarifying effective regulation and evaluation of digital mental health technology (DMHT).

Background

The project will improve outcomes for people with mental health conditions by enabling access to safe and effective digital mental health technologies. This will be achieved by ensuring that digital mental health technologies are regulated through continuous evaluation to minimise risk.​

MHRA is leading this project, in partnership with NICE, and they are engaging with a wide range of stakeholders, including:

  • clinicians
  • researchers
  • industry
  • lived / living experience advisors
  • patients and the public
  • international regulators
  • health technology appraisal organisations
  • UK and international policy makers
  • charities.

Phase 1 commenced in May 2023. Building on its work and learning, Phase 2 commenced in May 2026 and will continue until autumn 2028, with a focus on further developing proportionate approaches to the regulation and evaluation of DMHTs through targeted initiatives and continued stakeholder engagement. More about Phase 2.

A broad range of outputs across the project have been produced and these are shown for phase 1 to date.

Together, they support MHRA plans on implementing the medical devices future regime and the National Commission into the Regulation of AI in Healthcare work.

Phase 1

MHRA Guidance

Digital mental health technology: qualification and classification

Report on Adverse Event (AE) reporting in digital mental health technologies (DMHTs) and the development of updates to regulatory guidance

BSI standard

The MHRA has sponsored the BSI to develop this standard, which provides recommendations for designing and conducting pivotal clinical studies to generate evidence for DMHTs. It covers aspects such as: controls; sample characteristics; safety, effectiveness and engagement end points; and follow up periods. A technical author and steering group with a wide range of global expertise has supported the drafting and editing, There was a public consultation in June 2026 and the standard will be published early 2027.

Resources

Patient reported outcomes (PROs) resources for digital mental health technologies (DMHTs)

Interpreting small differences in health utilities and incremental QALYs (March 2026)

Yellow card reporting

Based on feedback, the yellow card reporting website has been edited to make it clearer that DMHT issues can be reported via this route, supporting MHRA’s ongoing safety monitoring of medical devices and digital technologies - Yellow Card, Making medicines and medical devices safer

Online learning resources

The MHRA and NHS England’s MindEd Technology Enhanced Learning programme have published online resources to help the public and professionals understand what safe and effective digital mental health technologies look like in practice, and how to report concerns using the MHRA Yellow Card scheme.

The resources are tailored for public, patients and carers and health, social care and education professionals, including teachers, nurses, GPs and mental health practitioners. They are hosted on the MindEd website, and use tip sheets and animations to explain what technologies regulated as medical devices look like and how to select or recommend a product appropriate for use.

With DMHTs becoming well established within mental health services and also widely available to consumers directly, these MindEd resources provide clear information about the regulation of DMHTs for professionals and the public.

Webinar recordings

Review the recording of the Digital mental health technology project: Progress update and E-Learning webinar – 28 January 2026

Progress update and E-Learning webinar – 28 January 2026

Review the recording of our webinar from Thursday 15 May 2025:

Subject Matter Expert project update webinar

Published articles 

Considerations for regulation and evaluation of digital mental health technologies Sage Journals Digital Health, 4 November 2024

Building robust, proportionate and timely approaches to the regulation and evaluation of digital mental health technologies The Lancet Digital Health, 15 November 2024

Toward a New Conceptual Framework for Digital Mental Health Technologies: Scoping Review JMIR Mental Health, 19 February 2025

Strength of Evidence to Support Decision-Making on the Use of Digital Mental Health Technologies in NICE Evaluations: Cross-Sectional Analysis of Studies JMIR Mental Health, 7 April 2026

The impact of choice of health-related quality of life measure on outcomes in mental health: A systematic review and meta-analysis of head-to-head comparisons Value in Health, 16 June 2026

Artificial intelligence in digital mental health technology: Considerations for regulation Sage Journals Digital Health, 5 August 2026

A Lived Experience Perspective on Digital Regulatory Practices Journal of Psychiatric and Mental Health Nursing, 3 October 2026

Research Reports

Digital mental health technology: user and public perspectives (3 May 2024)

Digital mental health technology: user and public perspectives (20 November 2025)

Working group summaries

Role of the Digital Mental Health Technology (DMHT) Working group

Phase 2

Phase 2 builds on the work and learning from Phase 1, continuing the MHRA and NICE partnership to improve the regulation and evaluation of digital mental health technologies. Read the press release about Phase 2.

Community of Practice

The MHRA has launched a Community of Practice to help digital mental health technology developers and manufacturers strengthen regulatory understanding across the product life cycle. Collaborative, in-person sessions will explore common challenges including pre-market considerations, product classification and post-market surveillance.

Read the main blog about the community of practice.

Help shape the Community of Practice by completing the survey.

Project newsletters

Register your interest to receive project newsletters

DMHT Programme Evaluation

The MHRA, in collaboration with NICE, is seeking feedback on resources that have been developed through Phase 1 of the Wellcome Digital Mental Health Technologies (DMHT) Programme. The survey seeks to understand how these resources are being found and used, and whether they have contributed to changes in understanding, confidence, decision-making and professional practice. Responses are welcomed from developers, clinicians, researchers, policymakers, regulators, HTA organisations, industry representatives and members of the public with lived experience of using digital mental health technologies. The findings will inform future MHRA and NICE direction in Phase 2 of the DMHT programme.

For further information and access to the survey, see Digital Mental Health Technologies (DMHT) Phase 1 evaluation survey

Press releases